Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Int Immunopharmacol ; 44: 160-167, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28107753

RESUMO

This study aimed to investigate the effect of sulfated polysaccharide from red seaweed Solieria filiformis (Fraction F II) in the inflammatory hypernociception in the temporomandibular joint (TMJ) of rats. Male Wistar rats were pretreated (30min) with a subcutaneous injection (s.c.) of vehicle or FII (0.03, 0.3 or 3.0mg/kg) followed by intra-TMJ injection of 1.5% Formalin or 5-hydroxytryptamine (5-HT, 225µg/TMJ). In other set of experiments rats were pretreated (15min) with an intrathecal injection of the non-selective opioid receptors Naloxone, or µ-opioid receptor antagonist CTOP, or δ-opioid receptor Naltridole hydrochloride, or κ-opioid receptor antagonist Nor-Binaltorphimine (Nor-BNI) followed by injection of FII (s.c.). After 30min, the animals were treated with an intra-TMJ injection of 1.5% formalin. After TMJ treatment, behavioral nociception response was evaluated for a 45-min observation period, animals were terminally anesthetized and periarticular tissue, trigeminal ganglion and subnucleus caudalis (SC) were collected plasma extravasation and ELISA analysis. Pretreatment with F II significantly reduced formalin- and serotonin-induced TMJ nociception, inhibit the plasma extravasation and inflammatory cytokines release induced by 1.5% formalin in the TMJ. Pretreatment with intrathecal injection of Naloxone, CTOP, Naltridole or Nor-BNI blocked the antinociceptive effect of F II in the 1.5% formalin-induced TMJ nociception. In addition, F II was able to significantly increase the ß-endorphin release in the subnucleus caudalis. The results suggest that F II has a potential antinociceptive and anti-inflammatory effect in the TMJ mediated by activation of opioid receptors in the subnucleus caudalis and inhibition of the release of inflammatory mediators in the periarticular tissue.


Assuntos
Analgésicos Opioides/administração & dosagem , Analgésicos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Núcleo Caudado/efeitos dos fármacos , Dor/tratamento farmacológico , Polissacarídeos/uso terapêutico , Articulação Temporomandibular/efeitos dos fármacos , Analgésicos Opioides/efeitos adversos , Animais , Núcleo Caudado/metabolismo , Interações Medicamentosas , Interleucina-1beta/metabolismo , Masculino , Dor/induzido quimicamente , Polissacarídeos/química , Ratos , Ratos Wistar , Receptores Opioides/metabolismo , Alga Marinha/imunologia , Sulfatos/química , Articulação Temporomandibular/patologia , Fator de Necrose Tumoral alfa/metabolismo , beta-Endorfina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA